TITLE

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy

AUTHOR(S)
Mandal, Subrata; Sinha, Subijay; Abbas, Zahir; Venkatesh, Pradeep
PUB. DATE
July 2011
SOURCE
Indian Journal of Ophthalmology;Jul2011, Vol. 59 Issue 4, p338
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented which discusses the efficacy of intravitreal bevacizumab in treating central serous chorioretinopathy complicated with subfoveal choroidal neovascularization.
ACCESSION #
61834928

 

Related Articles

  • Effect of axial length on myopic choroidal neovascularization. Zhang, Zhen-Yong; Zhang, Xing-Ru; Chu, Ren-Yuan // Graefe's Archive of Clinical & Experimental Ophthalmology;Sep2013, Vol. 251 Issue 9, p2269 

    No abstract available.

  • Choroidal neovascularization and bevacizumab therapy in Aicardi syndrome. Wenick, Adam; Paskowitz, Daniel; Tauqir, M.; Nguyen, Quan // Graefe's Archive of Clinical & Experimental Ophthalmology;Mar2013, Vol. 251 Issue 3, p1015 

    No abstract available.

  • Intravitreal bevacizumab and diabetic papillopathy with macular edema. Joob, Beuy; Wiwanitkit, Viroj // Oman Journal of Ophthalmology;Feb2012, Vol. 5 Issue 1, p68 

    A letter to the editor in response to the article "Diabetic papillopathy with macular edema treated with intravitreal bevacizumab," by A.S. Al-Hinai and colleagues is presented.

  • Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis. Benoit, Amandine; Ducray, François; Cartalat-Carel, Stéphanie; Psimaras, Dimitri; Ricard, Damien; Honnorat, Jérôme // Journal of Neurology;Feb2011, Vol. 258 Issue 2, p328 

    A letter to the editor is presented which discusses a study regarding the positive therapeutic outcome of bevacizumab in a patient with brainstem radiation necrosis after a negative result of steroid treatment.

  • Low Dose of Bevacizumab Is Safe and Effective in Preventing Bleeding Episodes in Hereditary Hemorrhagic Telangiectasia. Lazaraki, Georgia; Akriviadis, Evangelos; Pilpilidis, Ioannis; Parisi, Ioanna; Tzilves, Dimitrios; Tarpangos, Anestis // American Journal of Gastroenterology;Dec2011, Vol. 106 Issue 12, p2204 

    A letter to the editor is presented in response to the article "Low Dose of Bevacizumab Is Safe and Effective in Preventing Bleeding Episodes in Hereditary Hemorrhagic Telangiectasia," by Georgia Lazaraki and colleagues that was published in a previous issue.

  • Comment on 'Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial'. Fayers, T. // Eye;Jun2011, Vol. 25 Issue 6, p820 

    A letter to the editor is presented in response to the article "Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial," by M. L. Subramanian and colleagues in the 2010 issue.

  • Reply to Chhablani. Forte, R.; Cennamo, G. L.; Finelli, M.; Farese, E.; D'Amico, G.; Nicoletti, G.; de Crecchio, G.; Cennamo, G. // Eye;Feb2011, Vol. 25 Issue 2, p254 

    A response by R. Forte and colleagues to a letter to the editor regarding their article "Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema" in the 2010 issue is presented.

  • A matter of public interest. Garattini, Silvio; Bertele, Vittorio // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/17/2010, Vol. 341 Issue 7764, p114 

    A letter to the editor is presented in response to the article "Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomized double masked study," by A. Tufail and colleagues in the June 10, 2010 issue.

  • Bevacizumab and the inverse postcode lottery. Harris, Matthew J. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/17/2010, Vol. 341 Issue 7764, p114 

    A letter to the editor is presented in response to the article "Bevacizumab for the treatment of neovascular age related macular degeneration," by U. Chakravarthy in the June 9, 2010 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics